Pilot CAR-T Cells Therapy for Children/Young Adults With CD19+ R/R Leukemia/Lymphoma
Status:
Recruiting
Trial end date:
2023-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to estimate the safety and the efficacy of CAR- T cells
immunotherapy for children/young adults with relapsed or refractory acute lymphoblastic
leukemia/lymphoma.
Phase:
Phase 1
Details
Lead Sponsor:
Belarusian Research Center for Pediatric Oncology, Hematology and Immunology